Trial Profile
Modulation of Mucosal and Systemic Immunity by Hormonal Contraceptives
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 18 Aug 2015
Price :
$35
*
At a glance
- Drugs Levonorgestrel (Primary) ; Medroxyprogesterone (Primary) ; Oral contraceptives
- Indications Pregnancy
- Focus Pharmacodynamics
- 16 Jan 2013 New trial record